sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 976-1000 out of 1344.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>

Public Release: 17-Sep-2015
The Breast
Study finds high proportion of advanced breast cancers in sub-Saharan Africa
In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d'Ivoire and Republic of Congo are detected only after they've become advanced.
The African Cancer Registry Network

Contact: David Sampson
American Cancer Society

Public Release: 17-Sep-2015
IDRI, Wellcome Trust team for tuberculosis vaccine trial in South Africa
Today, the Infectious Disease Research Institute (IDRI) and Wellcome Trust announce the start of a Phase 2a trial in South Africa of IDRI's tuberculosis vaccine candidate, which has been shown to both prevent and treat TB in preclinical studies in animal models. The Wellcome Trust awarded IDRI a $5.8 million/£3.8 million grant to clinically assess the ability of IDRI's vaccine candidate to reduce TB recurrence after treatment.
Wellcome Trust

Contact: Lee Schoentrup
Infectious Disease Research Institute

Public Release: 17-Sep-2015
Global consortium rewrites the 'cartography' of dengue virus
An international consortium of laboratories worldwide that are studying the differences among dengue viruses has shown that while the long-held view that there are four genetically-distinct types of the virus holds, far more important are the differences in their antigenic properties -- the 'coats' that the viruses wear that help our immune systems identify them.

Contact: Sarah Collins
University of Cambridge

Public Release: 17-Sep-2015
PLOS Neglected Tropical Diseases
Global burden of leptospirosis is greater than thought, and growing
The global burden of a tropical disease known as leptospirosis is far greater than previously estimated, resulting in more than 1 million new infections and nearly 59,000 deaths annually, a new international study led by the Yale School of Public Health has found.

Contact: Michael Greenwood
Yale University

Public Release: 16-Sep-2015
Scientific Reports
Scientists create immunity to deadly parasite by manipulating host's genes
Researchers have silenced genes within human cells to induce immunity to the parasite E. histolytica, demonstrating the effectiveness of an entirely new approach to protecting people from infectious diseases.

Contact: Josh Barney
University of Virginia Health System

Public Release: 16-Sep-2015
HIV cure, better therapies subjects of $6.3 million in grants to Pitt vaccine scientist duo
A husband-wife team researching a cure for HIV/AIDS at the University of Pittsburgh Center for Vaccine Research recently received $6.3 million total in two grants from the National Institutes of Health. The grants are the latest in the team's successful run garnering NIH support for their HIV research, now totaling $23 million since they came to Pitt six years ago.
National Institutes of Health

Contact: Allison Hydzik
University of Pittsburgh Schools of the Health Sciences

Public Release: 15-Sep-2015
Skin microbiome influences common sexually transmitted disease
For years, researchers have known that the human skin is home to a diverse community of microorganisms, collectively known as the skin microbiome. Now a new study has shown that individuals with a particular skin microbiome can effectively clear bacteria that cause chancroid, a sexually transmitted disease common in the developing world that has been linked to enhanced HIV transmission.

Contact: Aleea Khan
American Society for Microbiology

Public Release: 15-Sep-2015
PLOS Medicine
Electronic reminders keep TB patients on track with medication in China
Giving electronic reminders to tuberculosis patients in China can reduce the amount of medication doses they miss by half, according to new research from the London School of Hygiene & Tropical Medicine and the National Center for Tuberculosis Control and Prevention in China.
Bill & Melinda Gates Foundation

Contact: Katie Steels
London School of Hygiene & Tropical Medicine

Public Release: 14-Sep-2015
UNITAID and EGPAF launch initiative to significantly scale up early infant HIV diagnosis
UNITAID and the Elizabeth Glaser Pediatric AIDS Foundation today launched an initiative that will dramatically scale up HIV diagnosis among newborns in nine African countries. In partnership with ministries of health, this initiative will make 'point-of-care' testing more widely available to HIV-exposed infants early in their lives, when they are most at risk of dying, and enable those diagnosed with the virus to be put on lifesaving treatment more quickly.

Contact: Johanna Harvey
Elizabeth Glaser Pediatric AIDS Foundation

Public Release: 11-Sep-2015
Health Affairs
Achieving effective health care with a new approach to caring for chronic illnesses
Researchers from the University of Miami and Harvard University address the challenges of effective universal health coverage in low- and middle-income countries, focusing on solving one of the most pressing issues: the care of chronic illnesses. Their suggestions, aimed at strengthening health care systems, include recommendations based on a 'diagonal approach' for managing health care.

Contact: Megan Ondrizek
University of Miami

Public Release: 11-Sep-2015
Cell Reports
Ebola virus mutations may help it evade drug treatment
Genetic mutations called 'escape variants' in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of US Army scientists and collaborators. Their findings, published online this week in the journal Cell Reports, have implications for the continued development of therapeutics to treat Ebola virus disease, which has claimed the lives of over 11,000 people in West Africa since last year.
Defense Threat Reduction Agency

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 11-Sep-2015
Angewandte Chemie
A better class of cancer drugs
A class of therapeutic drugs known as protein kinase inhibitors has become a powerful weapon in the fight against various life-threatening diseases. One problem with these drugs, however, is that they often inhibit many different targets, which can lead to side effects and complications in therapeutic use. A recent study by SDSU chemist Jeffrey Gustafson has identified a new technique for improving the selectivity of these drugs and possibly decreasing unwanted side effects in the future.

Contact: Beth Chee
San Diego State University

Public Release: 10-Sep-2015
Malaria Journal
African dams linked to over 1 million malaria cases annually
A new peer-reviewed study that for the first time correlates the location of large dams with the incidence of malaria and quantifies the impacts across sub-Saharan Africa. The study looked at over 1,200 dams and found that the population at risk for malaria around dams is at least four times greater than previously estimated.

Contact: James Clarke

Public Release: 10-Sep-2015
Poor diet and high blood pressure now number 1 risk factors for death
New global burden of disease study finds a huge amount of deaths worldwide are due to preventable risk-factors.

Contact: Jane Gardner
University of Melbourne

Public Release: 10-Sep-2015
Cancer Epidemiology
Breast cancer incidence, death rates rising in some economically transitioning countries
A new study finds breast cancer incidence and death rates are increasing in several low and middle income countries, even as death rates have declined in most high income countries, despite increasing or stable incidence rates.
American Cancer Society

Contact: David Sampson
American Cancer Society

Public Release: 10-Sep-2015
The Lancet
Avoidable risk factors take an increasing toll on health worldwide
A wide range of avoidable risk factors to health -- ranging from air pollution to poor diets to unsafe water -- account for a growing number of deaths and a significant amount of disease burden, according to a new analysis of 79 risks in 188 countries.

Contact: Rhonda Stewart
Institute for Health Metrics and Evaluation

Public Release: 9-Sep-2015
Ebola virus disease in Liberia
A newly published research study by US Forest Service researchers demonstrates that the social vulnerability indices used in climate change and natural hazards research can also be used in other contexts such as disease outbreaks. Authors of the article include Forest Service Southern Research Station researchers John Stanturf, Scott Goodrick, Mel Warren, and Christie Stegall, and Susan Charnley from the Forest Service Pacific Northwest Research Station.

Contact: John Stanturf
USDA Forest Service ‑ Southern Research Station

Public Release: 9-Sep-2015
PLOS Neglected Tropical Diseases
Brain plasticity in the most dreaded biblical disease
A new study shows that nerve damage caused by leprosy is associated to changes in the brain of patients.
National Counsel of Technological and Scientific Development, Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro, Brazilian Innovation Agency, and others

Contact: Claudia Vargas
Publicase Comunicação Científica

Public Release: 9-Sep-2015
Science Translational Medicine
Study IDs viral protein that causes dengue shock
UC Berkeley scientists have identified a viral protein secreted by cells infected with the dengue virus as a key culprit behind the fluid loss and resulting shock that are the hallmark of severe -- and potentially fatal -- infections.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Yang
University of California - Berkeley

Public Release: 9-Sep-2015
Science Translational Medicine
UQ scientists close in on first dengue treatment
Clinical trials for a dengue fever treatment could start within a year, following a discovery by University of Queensland scientists. UQ's School of Chemistry and Molecular Biosciences Head Professor Paul Young said the researchers had identified similarities in how the body reacted to dengue virus and bacterial infections, in a finding that would allow them to repurpose existing drugs.
National Health and Medical Research Council

Contact: Paul Young
University of Queensland

Public Release: 8-Sep-2015
The FASEB Journal
Hypertension in professional football players likely results from trauma on the field
The regular physical trauma that appears to put professional football players at risk for degenerative brain disease may also increase their risk for hypertension and cardiovascular disease, researchers say.
American Heart Association, National Institutes of Health

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 8-Sep-2015
Angewandte Chemie International Edition
Pitt researchers developing a novel way to identify pathogens
The University of Pittsburgh's Xinyu Liu, Sanford Asher, and colleagues may have found a faster method to identify pathogens.

Contact: Joe Miksch
University of Pittsburgh

Public Release: 8-Sep-2015
Drugs for Neglected Diseases initiative unveils new plan for neglected patients
After having built the world's largest drug development pipeline for the most neglected diseases, the Drugs for Neglected Diseases initiative has unveiled plans for a more flexible, dynamic portfolio approach, integrating various operating models to better respond to the needs of patients, notably in low- and middle-income countries. The plan also paves the way for new diseases to be taken up in DNDi's portfolio.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 8-Sep-2015
European Congress on Tropical Medicine and International Health ECTMIH
Clinical trial for first oral drug candidate specifically developed for sleeping sickness
The Drugs for Neglected Diseases initiative has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 8-Sep-2015
Umeå researcher explains the increase in dengue epidemics in Singapore
Population growth and increased temperature are the most important explanations to the significant increase of dengue incidence in Singapore since the 1970s. This is shown in a study undertaken by Joacim Rocklöv and his colleagues at the unit of Epidemiology and Global Health at Umeå University in Sweden, published in the journal PLOS ONE.

Contact: Mattias Grundström Mitz
Umea University

Showing releases 976-1000 out of 1344.

<< < 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 > >>